-
公开(公告)号:US06787649B2
公开(公告)日:2004-09-07
申请号:US10258624
申请日:2003-02-12
IPC分类号: C07D50136
CPC分类号: C07D501/00 , C07D277/46
摘要: A process which comprises (i) acylating a compound of formula II with a compound of formula IV to obtain a compound of formula I and (ii) deformylating said compound of formula I to obtain a compound of formula III
摘要翻译: 一种方法,其包括(i)用式IV化合物酰化式II化合物以获得式I化合物和(ii)使所述式I化合物变形,得到式III化合物
-
公开(公告)号:US07825241B2
公开(公告)日:2010-11-02
申请号:US11766132
申请日:2007-06-21
IPC分类号: C07D501/22
CPC分类号: C07D501/00
摘要: 7-[2-(2-aminothiazol-4-yl)-2-(methylcarbonyloxyimino)acetamido]-3-vinyl-cephem-4-carboxylic acid of formula (I), in the form of a crystalline salt and use thereof, e.g. in the preparation of pure cefdinir. In another aspect this invention relates to the compound of formula (I) in the form of a salt, optionally in crystalline form, wherein the salt is selected from the group consisting of phosphate, hydrogen phosphate, mesylate, tosylate, sulfate, hydrogen sulfate and sulfamate.
摘要翻译: 以式(I)表示的7- [2-(2-氨基噻唑-4-基)-2-(甲基羰氧基亚氨基)乙酰氨基] -3-乙烯基头孢烯-4-羧酸的结晶盐及其用途, 例如 在制备纯头孢地尼。 另一方面,本发明涉及任选呈结晶形式的盐形式的式(I)化合物,其中所述盐选自磷酸盐,磷酸氢盐,甲磺酸盐,甲苯磺酸盐,硫酸盐,硫酸氢盐和 氨基磺酸盐。
-
公开(公告)号:US20060025586A1
公开(公告)日:2006-02-02
申请号:US10524397
申请日:2003-08-12
IPC分类号: C07D501/14
CPC分类号: C07D501/00
摘要: 7-[2-(2-aminothiazol-4-yl)-2-(methylcarbonyloxyimino)acetamido]-3-vinyl-cephem-4-carboxylic acid of formula I in the form of a crystalline salt and use thereof, e.g. in the preparation of pure cefdinir. In another aspect this invention relates to the compound of formula I in the form of a salt, optionally in crystalline form, wherein the salt is selected from the group consisting of phosphate, hydrogen phosphate, mesylate, tosylate, sulfate, hydrogen sulfate and sulfamate.
摘要翻译: 具有结晶盐形式的式I的7- [2-(2-氨基噻唑-4-基)-2-(甲基羰氧基亚氨基)乙酰氨基] -3-乙烯基头孢烯-4-羧酸及其用途, 在制备纯头孢地尼。 在另一方面,本发明涉及任选呈结晶形式的盐形式的式I化合物,其中盐选自磷酸盐,磷酸氢盐,甲磺酸盐,甲苯磺酸盐,硫酸盐,硫酸氢盐和氨基磺酸盐。
-
公开(公告)号:US20080081906A1
公开(公告)日:2008-04-03
申请号:US11766132
申请日:2007-06-21
IPC分类号: C07D277/02 , C07D279/04
CPC分类号: C07D501/00
摘要: 7-[2-(2-aminothiazol-4-yl)-2-(methylcarbonyloxyimino)acetamido]-3-vinyl-cephem-4-carboxylic acid of formula (I), in the form of a crystalline salt and use thereof, e.g. in the preparation of pure cefdinir. In another aspect this invention relates to the compound of formula (I) in the form of a salt, optionally in crystalline form, wherein the salt is selected from the group consisting of phosphate, hydrogen phosphate, mesylate, tosylate, sulfate, hydrogen sulfate and sulfamate.
摘要翻译: 以式(I)表示的7- [2-(2-氨基噻唑-4-基)-2-(甲基羰氧基亚氨基)乙酰氨基] -3-乙烯基头孢烯-4-羧酸的结晶盐及其用途, 例如 在制备纯头孢地尼。 另一方面,本发明涉及任选呈结晶形式的盐形式的式(I)化合物,其中所述盐选自磷酸盐,磷酸氢盐,甲磺酸盐,甲苯磺酸盐,硫酸盐,硫酸氢盐和 氨基磺酸盐。
-
公开(公告)号:US07250508B2
公开(公告)日:2007-07-31
申请号:US10524397
申请日:2003-08-12
IPC分类号: C07D501/22 , C07D417/12
CPC分类号: C07D501/00
摘要: 7-[2-(2-aminothiazol-4-yl)-2-(methylcarbonyloxyimino)acetamido]-3-vinyl-cephem-4-carboxylic acid of formula I in the form of a crystalline salt and use thereof, e.g. in the preparation of pure cefdinir. In another aspect this invention relates to the compound of formula I in the form of a salt, optionally in crystalline form, wherein the salt is selected from the group consisting of phosphate, hydrogen phosphate, mesylate, tosylate, sulfate, hydrogen sulfate and sulfamate.
摘要翻译: 具有结晶盐形式的式I的7- [2-(2-氨基噻唑-4-基)-2-(甲基羰氧基亚氨基)乙酰氨基] -3-乙烯基头孢烯-4-羧酸及其用途, 在制备纯头孢地尼。 在另一方面,本发明涉及任选呈结晶形式的盐形式的式I化合物,其中盐选自磷酸盐,磷酸氢盐,甲磺酸盐,甲苯磺酸盐,硫酸盐,硫酸氢盐和氨基磺酸盐。
-
公开(公告)号:US09139597B2
公开(公告)日:2015-09-22
申请号:US13320430
申请日:2010-05-25
IPC分类号: C07D501/56 , C07D501/04 , C07D501/18
CPC分类号: C07D501/56 , C07D501/04 , C07D501/18
摘要: The present invention relates to a method for the production of organic compounds, in particular sodium (6R,7R)-7-[(Z)-2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-hydroxyimino-acetylamino]-8-oxo-3-[(E)-(R)-1′-(5-methyl-2-oxo-[1,3]-dioxol-4-ylmethoxycarbonyl)-2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl]-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate (ceftobiprole medocaril), and compounds of the general formula (1) and of the general formula (2), the compounds themselves and intermediates in the production according to the invention.
摘要翻译: 本发明涉及一种生产有机化合物的方法,特别是(6R,7R)-7 - [(Z)-2-(5-氨基 - [1,2,4]噻二唑-3-基) -2-羟基亚氨基 - 乙酰氨基] -8-氧代-3 - [(E) - (R)-1' - (5-甲基-2-氧代 - [1,3] - 二氧杂环戊烯-4-基甲氧基羰基)-2- 氧基 - [1,3']联吡咯烷基-3-亚基甲基] -5-硫杂-1-氮杂 - 双环[4.2.0]辛-2-烯-2-羧酸酯(头孢噻肟中间体)和通式( 1)和通式(2),本发明的生产中的化合物本身和中间体。
-
公开(公告)号:US09096610B2
公开(公告)日:2015-08-04
申请号:US13320414
申请日:2010-05-25
IPC分类号: C07D501/56 , C07D501/04 , C07D501/18
CPC分类号: C07D501/56 , C07D501/04 , C07D501/18
摘要: The present invention relates to a method for the production of organic compounds, in particular sodium (6R,7R)-7-[(Z)-2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-hydroxyimino-acetylamino]-8-oxo-3-[(E)-(R)-1′-(5-methyl-2-oxo-[1,3]-dioxol-4-ylmethoxycarbonyl)-2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl]-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate (ceftobiprole medocaril), and compounds of the general formula (1) and of the general formula (2), the compounds themselves and intermediates in the production according to the invention.
-
公开(公告)号:US20120116070A1
公开(公告)日:2012-05-10
申请号:US13320414
申请日:2010-05-25
IPC分类号: C07D501/46 , C07D501/18
CPC分类号: C07D501/56 , C07D501/04 , C07D501/18
摘要: The present invention relates to a method for the production of organic compounds, in particular sodium (6R,7R)-7-[(Z)-2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-hydroxyimino-acetylamino]-8-oxo-3-[(E)-(R)-1′-(5-methyl-2-oxo-[1,3]-dioxol-4-ylmethoxycarbonyl)-2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl]-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate (ceftobiprole medocaril), and compounds of the general formula (1) and of the general formula (2), the compounds themselves and intermediates in the production according to the invention.
-
公开(公告)号:US20120108807A1
公开(公告)日:2012-05-03
申请号:US13320430
申请日:2010-05-25
IPC分类号: C07D501/56 , C07D501/18 , C07F7/18 , C07D501/04
CPC分类号: C07D501/56 , C07D501/04 , C07D501/18
摘要: The present invention relates to a method for the production of organic compounds, in particular sodium (6R,7R)-7-[(Z)-2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-hydroxyimino-acetylamino]-8-oxo-3-[(E)-(R)-1′-(5-methyl-2-oxo-[1,3]-dioxol-4-ylmethoxycarbonyl)-2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl]-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate (ceftobiprole medocaril), and compounds of the general formula (1) and of the general formula (2), the compounds themselves and intermediates in the production according to the invention.
摘要翻译: 本发明涉及一种生产有机化合物的方法,特别是(6R,7R)-7 - [(Z)-2-(5-氨基 - [1,2,4]噻二唑-3-基) -2-羟基亚氨基 - 乙酰氨基] -8-氧代-3 - [(E) - (R)-1' - (5-甲基-2-氧代 - [1,3] - 二氧杂环戊烯-4-基甲氧基羰基)-2- 氧基 - [1,3']联吡咯烷基-3-亚基甲基] -5-硫杂-1-氮杂 - 双环[4.2.0]辛-2-烯-2-羧酸酯(头孢噻肟中间体)和通式( 1)和通式(2),本发明的生产中的化合物本身和中间体。
-
公开(公告)号:US20160009745A1
公开(公告)日:2016-01-14
申请号:US14863982
申请日:2015-09-24
申请人: Peter Kremminger , Hubert Sturm
发明人: Peter Kremminger , Hubert Sturm
IPC分类号: C07F9/6561 , C07D501/04 , C07C51/41 , C07D417/04 , C07C303/22
CPC分类号: C07F9/65613 , C07C51/41 , C07C303/22 , C07D417/04 , C07D501/04 , C07D501/08 , C07D501/59
摘要: The present invention relates to a novel process for preparing ceftaroline fosamil via intermediates of Formulae (1), (3) or (4) of this process.
摘要翻译: 本发明涉及通过该方法的式(1),(3)或(4)的中间体制备头孢罗林粉剂的新方法。
-
-
-
-
-
-
-
-
-